When is the next results date for Abate As Indust?

No Upcoming Board Meetings

What is the technical trend for Abate As Indust?

As of May 19, 2025, Abate As Indust shows a mildly bearish trend due to daily moving averages and weekly RSI indicating bearish momentum, despite mixed signals from other indicators.

As of 19 May 2025, the technical trend for Abate As Indust has changed from does not qualify to mildly bearish. The current stance is mildly bearish, driven primarily by the daily moving averages indicating a bearish trend and the weekly RSI showing bearish momentum. While the weekly MACD and Bollinger Bands are mildly bullish, the monthly indicators remain bearish, suggesting a lack of strong upward momentum. The Dow Theory indicates no trend on the weekly timeframe, but mildly bullish on the monthly, adding to the mixed signals. Overall, the strength of the bearish stance is supported by the daily moving averages and the weekly RSI.

Who are the peers of the Abate As Indust?

Abate As Indust's peers include Shalby, Dr Agarwal's Eye, GPT Healthcare, and others, with varying management and growth risks. In terms of returns, Abate As Indust has a 1-year return of 46.07%, higher than Shalby's -33.71% but lower than Asarfi Hospital's 92.36%.

Peers: The peers of Abate As Indust are Shalby, Dr Agarwal's Eye, GPT Healthcare, KMC Speciality, Asarfi Hospital, Aashka Hospitals, Chandan Healthca, Aprameya Enginee, and Unihealth Hosp.<BR><BR>Quality Snapshot: Excellent management risk is observed at GPT Healthcare and Chandan Healthca, while Good management risk is found at Shalby, Asarfi Hospital, Aprameya Enginee, and Unihealth Hosp. Average management risk is present at Dr Agarwal's Eye, KMC Speciality, and Aashka Hospitals, while Below Average management risk is noted at Aashka Hospitals. Abate As Indust does not qualify for management risk assessment. In terms of growth, Excellent growth is seen at Chandan Healthca and Aprameya Enginee, while Average growth is found at Dr Agarwal's Eye and Unihealth Hosp. Below Average growth is noted at Shalby, GPT Healthcare, KMC Speciality, Asarfi Hospital, and Aashka Hospitals. Abate As Indust does not qualify for growth assessment. For capital structure, Excellent capital structure is observed at GPT Healthcare and KMC Speciality, while Good capital structure is found at Shalby and Asarfi Hospital. Average capital structure is noted at Dr Agarwal's Eye and Unihealth Hosp, while Below Average capital structure is seen at Aashka Hospitals and Abate As Indust does not qualify for capital structure assessment.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Asarfi Hospital at 92.36%, while the lowest is Shalby at -33.71%. Abate As Indust has a 1-year return of 46.07%, which is significantly higher than Shalby but lower than Asarfi Hospital. Additionally, KMC Speciality, Aashka Hospitals, and Shalby have negative six-month returns.

Who are in the management team of Abate As Indust?

As of March 2018, the management team of Abate As Indust includes Kamlesh B Mehta (Executive Director), Visswas B Panse (Independent Non-Executive Director), and Ashok Bhanushali (Non-Executive Director).

As of March 2018, the management team of Abate As Indust includes the following members:<BR><BR>1. Kamlesh B Mehta - Executive Director<BR>2. Visswas B Panse - Independent Non-Executive Director<BR>3. Ashok Bhanushali - Non Executive Director<BR><BR>These individuals are part of the company's Board of Directors.

What does Abate As Indust do?

Abate As Industries Ltd specializes in accounting and finance software for the hospital industry, with a market cap of INR 340 Cr and a recent quarterly profit of 6 Cr as of March 2025. The company has a high P/E ratio of 315.00 and a low return on equity of -0.18%.

Overview:<BR>Abate As Industries Ltd is a specialist in accounting software packages and finance software packages, operating within the hospital industry and categorized as a micro-cap company.<BR><BR>History:<BR>The company was incorporated in an unspecified year, with no status changes reported. The latest quarter for which sales and profit are reported is March 2025.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: 6 Cr (Quarterly Results - Mar 2025)<BR>Market-cap value: INR 340 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 315.00<BR>Industry P/E: 35<BR>Dividend Yield: 0.00%<BR>Debt Equity: 0.01<BR>Return on Equity: -0.18%<BR>Price to Book: 2.07<BR><BR>Contact Details:<BR>Address: Siddhart Nagar No 5 S V Road, Chawl 19/168 Goregaon West Mumbai Maharashtra : 400062<BR>Email: k4kamleshm@yahoo.com<BR>Website: http://www.abateas.com

Who are the top shareholders of the Abate As Indust?

The top shareholders of Abate As Indust are the Al Salama Eye Research Foundation with 12.75%, followed by Kanta Devi Samdaria at 2.39%, while individual investors hold a combined 58.46%. There are no institutional holdings from mutual funds or foreign investors.

The top shareholders of Abate As Indust include the Al Salama Eye Research Foundation, which holds the largest stake at 12.75%. The highest public shareholder is Kanta Devi Samdaria, with a holding of 2.39%. Additionally, individual investors collectively hold a significant portion of 58.46%. There are no institutional holdings from mutual funds or foreign institutional investors.

Is Abate As Indust overvalued or undervalued?

As of July 17, 2025, Abate As Indust is considered very expensive and overvalued, with a PE ratio of 321.59, significantly higher than its peers, and a recent stock performance of 111.65% compared to the Sensex's 0.83%.

As of 17 July 2025, the valuation grade for Abate As Indust has moved from does not qualify to very expensive, indicating a significant shift in its perceived value. The company is currently considered overvalued. Key ratios include a PE ratio of 321.59, an EV to EBIT of 362.63, and an ROE of 0.67%. <BR><BR>In comparison to its peers, Abate As Indust's valuation metrics are starkly high; for instance, Elitecon International has a PE ratio of 273.4, while Lloyds Enterprises stands at 178.83. This suggests that Abate As Indust is priced at a premium compared to its competitors. Additionally, the company's recent stock performance has outpaced the Sensex, with a 1-month return of 111.65% compared to the Sensex's 0.83%, reinforcing the notion of an inflated valuation.

How big is Abate As Indust?

As of 24th July, Abate As Industries Ltd has a market capitalization of 383.00 Cr, with reported Net Sales of 0.00 Cr and a Net Profit loss of 1.86 Cr in the latest four quarters. Shareholder's Funds are valued at 163.79 Cr, and Total Assets amount to 205.47 Cr.

As of 24th July, Abate As Industries Ltd has a market capitalization of 383.00 Cr, categorized as a Micro Cap.<BR><BR>In the latest four quarters, the company reported Net Sales of 0.00 Cr and a Net Profit loss of 1.86 Cr.<BR><BR>For the latest annual period, the Shareholder's Funds were valued at 163.79 Cr, while the Total Assets amounted to 205.47 Cr.

Are Abate As Indust latest results good or bad?

Abate As Industries reported strong Q2 FY26 results, with a net profit of ₹4.07 crores and a revenue increase of 2.61%, indicating positive growth. However, concerns about low return on equity and high valuation suggest that the sustainability of this performance may be questionable.

Abate As Industries has recently reported strong financial results for Q2 FY26, indicating a positive trajectory for the company. The net profit for the quarter reached ₹4.07 crores, which represents a remarkable 80.89% increase compared to the previous quarter. Additionally, revenue grew by 2.61% to ₹42.13 crores, marking the highest quarterly revenue since the company resumed operations.<BR><BR>The operating margin also showed significant improvement, rising to 9.14%, up 303 basis points from the prior quarter. The profit after tax (PAT) margin increased to 9.66%, reflecting a solid operational performance. These results are particularly noteworthy given the company's long history of minimal revenue prior to its recent revival.<BR><BR>However, while the recent performance is encouraging, there are concerns regarding the sustainability of this growth. The company's return on equity (ROE) is very low at 0.67%, and its return on capital employed (ROCE) is just 0.12%, indicating challenges in capital efficiency. Additionally, the valuation metrics suggest that the stock is trading at a very high price-to-earnings ratio of 252.89x, which may not be justified given the current profitability levels.<BR><BR>In summary, while Abate As Industries' latest results show significant improvement and a positive trend, the underlying operational efficiency and high valuation raise questions about the sustainability of this performance. Investors should weigh these factors carefully.

How has been the historical performance of Abate As Indust?

Abate As Indust reported an operating income of 14.09 Cr and a profit after tax of 1.11 Cr for the year ending March 2025, with an EPS of 0.07 and strong profit margins of 5.25% and 7.81%. The company has total liabilities of 205.47 Cr and shareholder's funds of 163.79 Cr, indicating a solid financial position.

Answer:<BR>The historical performance of Abate As Indust shows a total operating income of 14.09 Cr for the year ending March 2025, with a total expenditure of 13.35 Cr, resulting in an operating profit (PBDIT) of 1.71 Cr. After accounting for interest and depreciation, the profit before tax stands at 1.10 Cr, leading to a profit after tax of 1.11 Cr. The earnings per share (EPS) for the same period is reported at 0.07. The company maintains a strong operating profit margin of 5.25% and a profit after tax margin of 7.81%. <BR><BR>Breakdown:<BR>Abate As Indust reported a total operating income of 14.09 Cr, with raw material costs and other operating expenses contributing to a total expenditure of 13.35 Cr. This resulted in an operating profit of 1.71 Cr, which, after deducting interest and depreciation, led to a profit before tax of 1.10 Cr and a profit after tax of 1.11 Cr. The company’s earnings per share is 0.07, reflecting its profitability. The operating profit margin is 5.25%, while the profit after tax margin is notably higher at 7.81%. On the balance sheet, total liabilities amount to 205.47 Cr, with shareholder's funds at 163.79 Cr, indicating a solid financial foundation. The cash flow from financing activities shows a net inflow of 164.00 Cr, contributing to a closing cash equivalent of 1.00 Cr.

Should I buy, sell or hold Abate As Indust?

Which are the latest news on Abate As Indust?

Why is Abate As Indust falling/rising?

As of 04-Dec, Abate As Industries Ltd's stock price is rising to 17.98, reflecting a 3.51% increase. This rise is supported by strong recent performance compared to the Sensex, despite a decline in investor participation.

As of 04-Dec, Abate As Industries Ltd's stock price is rising, currently at 17.98, reflecting an increase of 0.61 (3.51%). This upward movement can be attributed to several factors. Over the past week, the stock has outperformed the benchmark Sensex, which has declined by 0.53%, while Abate As Industries Ltd has shown a slight gain of 0.06%. In the last month, the stock has risen by 4.66%, significantly outperforming the Sensex's 2.16% increase.<BR><BR>Moreover, the stock has been on a positive trend, gaining for the last three consecutive days and achieving a total return of 7.66% during this period. It is also noteworthy that the current price is above the 5-day, 20-day, 50-day, and 200-day moving averages, indicating a strong short-term performance, although it is below the 100-day moving average.<BR><BR>However, there is a decline in investor participation, as evidenced by a significant drop in delivery volume, which fell by 61.95% compared to the 5-day average. Despite this decrease in participation, the stock remains liquid enough for trading, suggesting that the price rise is supported by existing market interest. Overall, the combination of recent performance and relative strength against the benchmark contributes to the stock's rising price.